Medical University of Graz

Graz, Styria 8036

0 studies enrolling now · 6 studies all time

What they study most

Autosomal Dominant Optic Atrophy, Burns, Follicular Lymphoma (FL), IGA Nephropathy, Kjer Optic Atrophy, Melanoma, Optic Atrophies, Hereditary, Optic Atrophy, Autosomal Dominant

Studies at this site

• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
• A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma — Running, not enrolling
• Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation — Stopped early
• The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury — Status unconfirmed
• Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy — Completed